These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. STUDY OF FIBRINOGEN TURNOVER RATES AFTER TOTAL HEPATECTOMY IN DOGS. GANS H Surgery; 1964 Apr; 55():544-50. PubMed ID: 14138019 [No Abstract] [Full Text] [Related]
4. [HEMORRHAGIC DIATHESIS AND THE PHENOMENON OF FIBRINOLYSIS, WITH SPECIAL REFERENCE TO ITS INHIBITION]. SHIMIZU M; HAYASHI H Chiryo; 1964; 46():879-86. PubMed ID: 14144012 [No Abstract] [Full Text] [Related]
5. THE ROLE OF FIBRINOLYSIN AND PROFIBRINOLYSIN ACTIVATOR IN HEMOPHILIA. REID WO; HOLBURN RR; DESIPIN MT; TOCANTINS LM Am J Med Sci; 1965 May; 249():518-33. PubMed ID: 14280891 [No Abstract] [Full Text] [Related]
6. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS]. WEISS M; YVER J; SAMAMA M; DUBOST C Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607 [No Abstract] [Full Text] [Related]
7. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS. KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647 [No Abstract] [Full Text] [Related]
8. [RECENT INFORMATION ON THE THERAPY OF BLOOD DISEASES]. HASEGAWA Y; TSUKADA R Chiryo; 1964; 46():501-9. PubMed ID: 14126913 [No Abstract] [Full Text] [Related]
9. THE USE OF THE SERIAL THROMBIN TIME IN EVALUATING THERAPY WITH EPSILON AMINOCAPROIC ACID IN MASSIVE THROMBOLYSIS AND PROTEOLYSIS. BRODSKY I; ROSS E; REID WO Am J Clin Pathol; 1964 Jun; 41():589-96. PubMed ID: 14183048 [No Abstract] [Full Text] [Related]
10. [TREATMENT OF HEMORRHAGIC DISEASES WITH EPSILON-AMINOCAPROIC ACID IN OBSTETRICS AND GYNECOLOGY]. MARZETTI L Clin Ostet Ginecol; 1964 Jun; 66():311-32. PubMed ID: 14173903 [No Abstract] [Full Text] [Related]
11. [EFFECTIVENESS OF SPLENECTOMY IN SOME DISEASES OF THE BLOOD SYSTEM. 2. SPLENECTOMY AND HORMONE THERAPY IN WERLHOF'S DISEASE]. EFENDIEV FA; AKHUNDOVA AM; ABDULLAEV MM Probl Gematol Pereliv Krovi; 1964 Mar; 9():11-5. PubMed ID: 14165258 [No Abstract] [Full Text] [Related]
16. [PRESENT TRENDS IN THE THERAPY OF HYPERFIBRINOLYTIC STATES]. DETTORI AG; PONARI O Clin Ter; 1963 Oct; 27():97-114. PubMed ID: 14100829 [No Abstract] [Full Text] [Related]
17. CURRENT PROBLEMS IN HEMOSTASIS. TOCANTINS LM; REID WO; SILVER MJ; KAZAL LA Ann N Y Acad Sci; 1964 Jul; 115():21-30. PubMed ID: 14196071 [No Abstract] [Full Text] [Related]
18. PURPURA FULMINANS: A CASE WITH RECOVERY. VAN CREVEL D; VAN DER KOLK WF; MOCHTAR IA; MULLER J Clin Pediatr (Phila); 1965 Jan; 4():23-7. PubMed ID: 14245909 [No Abstract] [Full Text] [Related]
19. PURPURA FULMINANS: A CASE WITH RECOVERY. VAN CREVELD ; VAN CREVELD ; MOCHTAR IA; MULLER J Clin Pediatr (Phila); 1965 Jan; 4():23-7. PubMed ID: 14243918 [No Abstract] [Full Text] [Related]
20. ACTIVATION OF THE BLOOD FIBRINOLYTIC ENZYME SYSTEM BY PLATELETS. REID WO; SILVER MJ Am J Physiol; 1964 Jun; 206():1255-61. PubMed ID: 14191030 [No Abstract] [Full Text] [Related] [Next] [New Search]